NOT-AI-19-037: Notice of NIAID Research Objectives added to PAR-19-134 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Notice of NIAID Research Objectives added to PAR-19-134 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Notice Number: NOT-AI-19-037

Key Dates
Release Date : February 01, 2019

Related Announcements
PAR-19-134

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Allergy and Infectious Diseases (NIAID) has added its Research Objectives to PAR-19-134 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed).

The following sections of PAR-19-134 have been updated to reflect these changes:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Research Objectives of Participating NIH Institutes and Centers

National Institute of Allergy and Infectious Diseases (NIAID)

NIAID supports basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases, with the goal of developing new therapies, vaccines, diagnostic tests, and other technologies. Research areas include microbiology and infectious diseases, AIDS and AIDS -related research, immunology, allergy, transplantation, and biodefense.

https://www.niaid.nih.gov/research/role

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Diane Adger-Johnson, MPH
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2924
Email: [email protected]